TC
LEGN icon

Trust Company’s Legend Biotech LEGN Stock Holding History

Trust Company’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$219 Hold
11
– – ﹤0.01% 881
2026
Q2 		$318 Hold
11
– – ﹤0.01% 839
2026
Q1 		$199 Hold
11
– – ﹤0.01% 871
2025
Q4 		$239 Buy
+11
New +$315 ﹤0.01% 856

Other funds holding LEGN

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Trust Company's LEGN Position: Q3 2026 in Review

Trust Company held its Legend Biotech (LEGN) position steady in Q3 2026 at 11 shares worth $219. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Trust Company first reported a position in LEGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $318 in Q2 2026. 5 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Trust Company held 11 shares of Legend Biotech worth $219 as of Q3 2026.
  • Trust Company left its Legend Biotech share count unchanged in Q3 2026.
  • Legend Biotech made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #881 holding.
  • Trust Company first reported a position in Legend Biotech in Q4 2025 and has held it in 4 quarters since.
  • Trust Company's Legend Biotech position peaked at $318 in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.